Zeaxanthin Dipalmitate in the Treatment of Liver Disease

Abstract EN

Goji berry, Lycium barbarum, has been widely used in traditional Chinese medicine (TCM), but its properties have not been studied until recently.

The fruit is a major source of zeaxanthin dipalmitate (ZD), a xanthophyll carotenoid shown to benefit the liver.

Liver disease is one of the most prevalent diseases in the world.

Some conditions, such as chronic hepatitis B virus, liver cirrhosis, and hepatocellular carcinoma, remain incurable.

Managing them can constitute an economic burden for patients and healthcare systems.

Hence, development of more effective pharmacological drugs is warranted.

Studies have shown the hepatoprotective, antifibrotic, antioxidant, anti-inflammatory, antiapoptotic, antitumor, and chemopreventive properties of ZD.

These findings suggest that ZD-based drugs could hold promise for many liver disorders.

In this paper, we reviewed the current literature regarding the therapeutic effects of ZD in the treatment of liver disease.